Does Rallies show Form 4 insider transactions for ZLAB?

Yes. Rallies tracks ZLAB insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is ZLAB research on Rallies investment advice?

No. Rallies provides research, data, and educational context for ZLAB. It does not provide personalized investment advice.

ZLAB (Zai Lab Limited American Depositary Shares) Stock Analysis - Insider Trades

Zai Lab Limited American Depositary Shares (ZLAB) is a publicly traded Healthcare sector company. As of May 21, 2026, ZLAB trades at $18.44 with a market cap of $2.12B and a P/E ratio of -108.98. ZLAB moved +2.29% today. Year to date, ZLAB is +3.98%; over the trailing twelve months it is -42.35%. Its 52-week range spans $15.96 to $44.34. Analyst consensus is strong buy with an average price target of $34.27. Rallies surfaces ZLAB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading ZLAB stock inside the company?

Recent ZLAB insider activity includes Edmondson Frazor Titus III sold 3.52K, Du Ying sold 50.00K, Du Ying sold 16.23K, Du Ying sold 33.77K, and Smiley Joshua L sold 3.02K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

ZLAB Key Metrics

Key financial metrics for ZLAB
Metric	Value
Price	$18.44
Market Cap	$2.12B
P/E Ratio	-108.98
EPS	$-0.17
Dividend Yield	0.00%
52-Week High	$44.34
52-Week Low	$15.96
Volume	151
Avg Volume	0
Revenue (TTM)	$453.28M
Net Income	$-178.12M
Gross Margin	58.00%

Recent ZLAB Insider Trades

Edmondson Frazor Titus III sold 3.52K (~$71.01K) on May 14, 2026.
Du Ying sold 50.00K (~$1.00M) on May 14, 2026.
Du Ying sold 16.23K (~$315.58K) on May 13, 2026.
Du Ying sold 33.77K (~$682.89K) on May 13, 2026.
Smiley Joshua L sold 3.02K (~$61.69K) on Apr 6, 2026.

Latest ZLAB News

Zai Lab Wins FDA Fast Track for DLL3-Targeting Zocilurtatug Pelitecan in epNECs — May 11, 2026
Zai Lab Q4 Revenue Up 17% to $127.6M, zoci Delivers 80% Brain ORR — Feb 28, 2026

ZLAB Analyst Consensus

4 analysts cover ZLAB: 0 strong buy, 3 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $34.27.

Common questions about ZLAB

Who is trading ZLAB stock inside the company?: Recent ZLAB insider activity includes Edmondson Frazor Titus III sold 3.52K, Du Ying sold 50.00K, Du Ying sold 16.23K, Du Ying sold 33.77K, and Smiley Joshua L sold 3.02K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for ZLAB?: Yes. Rallies tracks ZLAB insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is ZLAB research on Rallies investment advice?: No. Rallies provides research, data, and educational context for ZLAB. It does not provide personalized investment advice.